KIWOOM Securities

039490 · KOSPI · ₩039490 · 키움증권

₩236,500▲ ₩5,500 (2.38%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

What brokers say about KIWOOM Securities

No public broker reports on this company yet.

Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.

AI summary of public information

An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.

Kiwoom Securities trades near its 52-week low after a steep share price fall, while earnings have grown strongly over the past two years.

Kiwoom Securities is a large Korean online brokerage whose trailing results to H1 2026 show revenue of ₩34.4T and net income of ₩1.7T, with ROE of 26.2%. The share price closed at ₩210,500 on 2026-10-26, down 20.9% over one month and 22.6% over one year, and sits close to its 52-week low of ₩205,000. Leverage is high, with liabilities at 1329.2% of equity and borrowings of ₩44.6T, and trailing free cash flow is negative at ₩-12.0T.

What stands out

  • Annual revenue rose from ₩9.5T in 2023 to ₩17.1T in 2025, and net income rose from ₩436B to ₩1.1T over the same period.
  • Trailing operating margin is 6.3%, below the 8.7% recorded for full-year 2025, and net income for the trailing period is ₩1.7T.
  • Valuation is low on the data given: P/E 3.2, P/B 0.7, dividend yield 5.5%, and a fair value model range of ₩349,587 to ₩631,303 with a base of ₩471,847.
  • Foreign ownership rose from 27.9% to 30.3% over 60 days, while institutions were net sellers (-₩22.7B) and retail was net sellers (-₩5.0B) over the last 20 days.
  • News flow includes a rise in retail balances of issued short-term notes, a DAPA sanction on subsidiary LIG D&A that the press says has limited short-term earnings impact, and a lowered target price on Green Cross citing weaker COVID treatment sales.

What to watch

  • The upcoming full earnings release, since the filings include an advance notice of earnings results dated 2026-10-23 and the data does not state the figures in detail.
  • Trend in the high borrowings and negative free cash flow, plus the trend in retail short-term note balances reported in the press.
  • Filings for new securities issuance and supplementary shelf registrations, which are listed in recent filings and may affect share count or funding.

Data as of Oct 26, 2026 · written 3d ago

This is not financial advice.

Also known as: KIWOOM Securities / 키움증권 / 039490 / KRX:039490

Source: KRX statistical information